Pacific Bio (PACB) Reports Q4 Revenues of $24.9 Million

Pacific Bio (NASDAQ: PACB) reported Q4 revenue of $24.9 million, versus $24.4 million reported last year.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics